International Society for Affective Disorders

International Society for Affective Disorders
Name	International Society for Affective Disorders
Formation	2005
Type	Learned society
Headquarters	Geneva, Switzerland
Region served	Global
Leader title	President
Leader name	Dr. Elena Martín

International Society for Affective Disorders is an international learned society dedicated to advancing research, clinical practice, and public understanding of mood and affective conditions. The organization connects clinicians, researchers, institutions, and advocacy groups across continents, facilitating collaborations among members from universities, hospitals, and policy bodies. It maintains ties with major psychiatry, neuroscience, and public health organizations to promote evidence-based approaches and translational research.

History

Founded in 2005 by a coalition of clinicians and researchers from institutions such as University of Oxford, Massachusetts General Hospital, Karolinska Institutet, University of Toronto, and University of Melbourne, the society emerged in response to gaps identified during meetings at World Psychiatric Association conferences and symposia hosted by National Institute of Mental Health, Max Planck Society, and Royal College of Psychiatrists. Early collaborators included investigators affiliated with Harvard Medical School, University College London, Johns Hopkins University, McGill University, and Monash University. Initial funding and organizational support drew on grants and awards from entities including Wellcome Trust, European Commission, Canadian Institutes of Health Research, National Institutes of Health, and philanthropic sources associated with Bill & Melinda Gates Foundation donors. Milestones in the society’s history include inaugural meetings held alongside the World Congress of Psychiatry, the establishment of an international registry inspired by projects at Stanford University and Yale University, and partnerships with clinical networks linked to American Psychiatric Association and European Psychiatric Association.

Mission and Objectives

The society’s mission aligns with priorities articulated by World Health Organization, United Nations, and major research funders such as Medical Research Council and NIHR. Objectives include promoting multidisciplinary research that bridges work at Columbia University, Uppsala University, ETH Zurich, and Peking University; supporting clinical guideline development akin to efforts by National Institute for Health and Care Excellence and Canadian Psychiatric Association; and advocating for policy informed by evidence generated in collaboration with groups like European Commission Directorate-General for Health and Australian National Health and Medical Research Council. The society emphasizes translational pipelines that connect basic science from laboratories at Salk Institute, Cold Spring Harbor Laboratory, Howard Hughes Medical Institute-affiliated centers, and Institut Pasteur to clinical trials conducted at centers including Cleveland Clinic and Mayo Clinic.

Membership and Governance

Membership spans individual investigators, clinicians, institutional members, and affiliate organizations such as university departments at Princeton University, Duke University, Imperial College London, and specialty centers like Sheffield Teaching Hospitals and Addenbrooke's Hospital. Governance is conducted by an elected board drawing from regions represented by African Union-associated networks, ASEAN member states, and regional chapters modeled after societies like American Neurological Association and European Society of Cardiology. Officers have included leaders from Stanford School of Medicine, Icahn School of Medicine at Mount Sinai, Seoul National University, and University of São Paulo. Committees address ethics, research standards, and diversity, with advisory input from institutions such as Johns Hopkins Bloomberg School of Public Health and London School of Hygiene & Tropical Medicine.

Conferences and Meetings

Annual congresses rotate among host cities that have included Geneva, Berlin, Toronto, Sydney, Tokyo, New York City, Buenos Aires, Cape Town, and Mumbai. Program committees collaborate with societies like International Neuropsychological Society and Society for Neuroscience to design sessions featuring speakers from National Academy of Medicine, Royal Society, Academy of Medical Sciences (UK), and major research centers. Special symposia have been organized in partnership with events such as the European College of Neuropsychopharmacology congress and the American College of Neuropsychopharmacology meeting, with satellite workshops at universities including University of California, San Francisco and McMaster University.

Research and Publications

The society supports multicenter studies on mood disorders, drawing on methods from labs at Massachusetts Institute of Technology, California Institute of Technology, Rockefeller University, and clinical trial networks affiliated with GlaxoSmithKline and Pfizer consortia. It publishes peer-reviewed outputs, white papers, and consensus statements in collaboration with journals associated with Wiley-Blackwell, Elsevier, Springer Nature, and professional periodicals such as The Lancet, JAMA, British Medical Journal, and specialty journals run by American Psychiatric Association. Working groups focus on biomarkers, digital phenotyping, and pharmacotherapy informed by trials registered with ClinicalTrials.gov and databases maintained by European Medicines Agency.

Education, Training, and Outreach

Educational initiatives include postgraduate courses accredited by bodies like European Board of Psychiatry, fellowship programs affiliated with Royal College of Physicians (UK), and online modules developed with partners at Coursera-hosted institutions and training centers such as Massachusetts General Hospital Institute of Health Professions. Outreach campaigns coordinate with NGOs including Mental Health America, World Federation for Mental Health, and Mind (charity) to raise awareness and reduce stigma in regions covered by UNICEF programs and Pan American Health Organization initiatives.

Partnerships and Funding

Strategic partnerships span universities, health systems, industry partners, and governmental funders such as European Commission, National Institutes of Health, Wellcome Trust, and national ministries of health including those of United Kingdom, Canada, and Australia. Philanthropic collaborations have involved foundations connected to Robert Wood Johnson Foundation, Koch Foundation, and corporate partners in biotechnology and digital health sectors headquartered near clusters like Silicon Valley and Cambridge, Massachusetts. Funding models combine membership dues, conference revenues, project grants from entities such as Horizon Europe and NIH BRAIN Initiative, and charitable donations coordinated with legal frameworks akin to those used by Charity Commission for England and Wales.

Category:Learned societies